Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and …

Background Patients with diabetes are known as an important high‐risk group for cerebral
mucormycosis (CM). Method We conducted a structured search using PubMed/MEDLINE to …

The ongoing COVID-19 pandemic has quickly become a health threat worldwide, with high
mortality and morbidity among patients with comorbidities. This viral infection promotes the …

Background Mucormycosis is a rare, invasive disease associated with high mortality rates,
produced by opportunistic pathogens related to the Mucorales order and characterised by a …

Effusion cytology plays multiple roles in the management of benign and malignant disease,
from primary diagnosis to tissue allocation for ancillary diagnostic studies and biomarker …

COVID-19 has been responsible for widespread morbidity and mortality worldwide. Invasive
mucormycosis has death rates scaling 80%. India, one of the countries hit worst by the …

The diagnosis and initiation of appropriate treatment against invasive fungal infections
depend upon accurate identification of pathogens by pathologists and clinical …

Nosocomial clusters of fungal infections, whilst uncommon, cannot be predicted and are
associated with significant morbidity and mortality. Here, we review reports of nosocomial …

Invasive fungal infections are increasing in prevalence because of an expanding population
of immunocompromised individuals. To reduce morbidity and mortality, it is critical to …

PCR-based methods applied to various body fluids emerged in recent years as a promising
approach for the diagnosis of mucormycosis. In this study, we set up and assess the value of …